{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:37:26Z","timestamp":1772887046486,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:00:00Z","timestamp":1610496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN\/06270-2019"],"award-info":[{"award-number":["RGPIN\/06270-2019"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The search continues for improved therapy for acute lymphoblastic leukemia (<jats:italic>a<\/jats:italic>LL), the most common malignancy in children. Recently, <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone was put forth as sensitizer for <jats:italic>a<\/jats:italic>LL chemotherapy. However, the specific target of <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone in leukemic cells and the mechanism by which it induces leukemic cell apoptosis remain to be defined. Here, we demonstrate that <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone induces leukemic cell apoptosis through activation of the mu1 subtype of opioid receptors (OPRM1). <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-Methadone evokes IP3R-mediated ER Ca<jats:sup>2+<\/jats:sup> release that is inhibited by OPRM1 loss. In addition, the rate of Ca<jats:sup>2+<\/jats:sup> extrusion following <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone treatment is reduced, but is accelerated by loss of OPRM1. These <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone effects cause a lethal rise in [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> that is again inhibited by OPRM1 loss, which then prevents <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone-induced apoptosis that is associated with activation of calpain-1, truncation of Bid, cytochrome C release, and proteolysis of caspase-3\/12. Chelating intracellular Ca<jats:sup>2+<\/jats:sup> with BAPTA-AM reverses <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone-induced apoptosis, establishing a link between the rise in [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> and <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone-induced apoptosis. Altogether, our findings point to OPRM1 as a specific target of <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone in leukemic cells, and that OPRM1 activation by <jats:sc>d<\/jats:sc>,<jats:sc>l<\/jats:sc>-methadone disrupts IP3R-mediated ER Ca<jats:sup>2+<\/jats:sup> release and rate of Ca<jats:sup>2+<\/jats:sup> efflux, causing a rise in [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> that upregulates the calpain-1-Bid-cytochrome C-caspase-3\/12 apoptotic pathway.<\/jats:p>","DOI":"10.1038\/s41598-020-80520-w","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:26:43Z","timestamp":1610537203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["d,l-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca2+ release and decrease in Ca2+ efflux, elevating [Ca2+]i"],"prefix":"10.1038","volume":"11","author":[{"given":"JungKwon","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesusa L.","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Guk","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"key":"80520_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2020.1770591","author":"S Capria","year":"2020","unstructured":"Capria, S. et al. A review of current induction strategies and emerging prognostic factors in the management of children and adolescents with acute lymphoblastic leukemia. Expert Rev. Hematol. https:\/\/doi.org\/10.1080\/17474086.2020.1770591 (2020).","journal-title":"Expert Rev. Hematol."},{"key":"80520_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1056\/NEJMra1400972","volume":"373","author":"SP Hunger","year":"2015","unstructured":"Hunger, S. P. & Mullighan, C. G. Acute lymphoblastic leukemia in children. N. Engl. J. Med. 373, 1541\u20131552. https:\/\/doi.org\/10.1056\/NEJMra1400972 (2015).","journal-title":"N. Engl. J. Med."},{"key":"80520_CR3","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1080\/14656566.2016.1250884","volume":"17","author":"X Thomas","year":"2016","unstructured":"Thomas, X. & Le Jeune, C. Treating adults with acute lymphocytic leukemia: New pharmacotherapy options. Expert Opin. Pharmacother. 17, 2319\u20132330. https:\/\/doi.org\/10.1080\/14656566.2016.1250884 (2016).","journal-title":"Expert Opin. Pharmacother."},{"key":"80520_CR4","first-page":"60","volume":"49","author":"C Friesen","year":"2011","unstructured":"Friesen, C., Bacher, S., Hormann, I., Roscher, M. & Miltner, E. Cytotoxic effects of opioids on cancer cell lines. Int. J. Clin. Pharmacol. Ther. 49, 60\u201362 (2011).","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"80520_CR5","doi-asserted-by":"publisher","first-page":"677","DOI":"10.18632\/oncotarget.952","volume":"4","author":"C Friesen","year":"2013","unstructured":"Friesen, C. et al. Cell death sensitization of leukemia cells by opioid receptor activation. Oncotarget 4, 677\u2013690. https:\/\/doi.org\/10.18632\/oncotarget.952 (2013).","journal-title":"Oncotarget"},{"key":"80520_CR6","doi-asserted-by":"publisher","first-page":"6059","DOI":"10.1158\/0008-5472.CAN-08-1227","volume":"68","author":"C Friesen","year":"2008","unstructured":"Friesen, C., Roscher, M., Alt, A. & Miltner, E. Methadone, commonly used as maintenance medication for outpatient treatment of opioid dependence, kills leukemia cells and overcomes chemoresistance. Cancer Res. 68, 6059\u20136064. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1227 (2008).","journal-title":"Cancer Res."},{"key":"80520_CR7","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.4161\/cc.28493","volume":"13","author":"C Friesen","year":"2014","unstructured":"Friesen, C. et al. Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma. Cell Cycle 13, 1560\u20131570. https:\/\/doi.org\/10.4161\/cc.28493 (2014).","journal-title":"Cell Cycle"},{"key":"80520_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1046\/j.1526-4637.2002.02047.x","volume":"3","author":"SM Fishman","year":"2002","unstructured":"Fishman, S. M., Wilsey, B., Mahajan, G. & Molina, P. Methadone reincarnated: Novel clinical applications with related concerns. Pain Med 3, 339\u2013348. https:\/\/doi.org\/10.1046\/j.1526-4637.2002.02047.x (2002).","journal-title":"Pain Med"},{"key":"80520_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1399-6576.2008.01597.x","volume":"52","author":"OM Fredheim","year":"2008","unstructured":"Fredheim, O. M., Moksnes, K., Borchgrevink, P. C., Kaasa, S. & Dale, O. Clinical pharmacology of methadone for pain. Acta Anaesthesiol. Scand. 52, 879\u2013889. https:\/\/doi.org\/10.1111\/j.1399-6576.2008.01597.x (2008).","journal-title":"Acta Anaesthesiol. Scand."},{"key":"80520_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/16612","volume":"397","author":"D Yin","year":"1999","unstructured":"Yin, D., Mufson, R. A., Wang, R. & Shi, Y. Fas-mediated cell death promoted by opioids. Nature 397, 218. https:\/\/doi.org\/10.1038\/16612 (1999).","journal-title":"Nature"},{"key":"80520_CR11","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bbrc.2009.11.074","volume":"391","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Toll-like receptor 2 is required for opioids-induced neuronal apoptosis. Biochem Biophys. Res. Commun. 391, 426\u2013430. https:\/\/doi.org\/10.1016\/j.bbrc.2009.11.074 (2010).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"80520_CR12","first-page":"366","volume":"299","author":"Y Xiao","year":"2001","unstructured":"Xiao, Y., Smith, R. D., Caruso, F. S. & Kellar, K. J. Blockade of rat alpha3beta4 nicotinic receptor function by methadone, its metabolites, and structural analogs. J. Pharmacol. Exp. Ther. 299, 366\u2013371 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"80520_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0304-3940(97)13391-2","volume":"223","author":"AL Gorman","year":"1997","unstructured":"Gorman, A. L., Elliott, K. J. & Inturrisi, C. E. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-d-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci. Lett. 223, 5\u20138. https:\/\/doi.org\/10.1016\/s0304-3940(97)13391-2 (1997).","journal-title":"Neurosci. Lett."},{"key":"80520_CR14","doi-asserted-by":"publisher","first-page":"PL45","DOI":"10.1016\/0024-3205(94)00426-s","volume":"56","author":"K Kristensen","year":"1995","unstructured":"Kristensen, K., Christensen, C. B. & Christrup, L. L. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 56, PL45\u2013PL50. https:\/\/doi.org\/10.1016\/0024-3205(94)00426-s (1995).","journal-title":"Life Sci."},{"key":"80520_CR15","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/jcp.25237","volume":"231","author":"PM Regan","year":"2016","unstructured":"Regan, P. M., Langford, D. & Khalili, K. Regulation and functional implications of opioid receptor splicing in opioid pharmacology and HIV pathogenesis. J. Cell Physiol. 231, 976\u2013985. https:\/\/doi.org\/10.1002\/jcp.25237 (2016).","journal-title":"J. Cell Physiol."},{"key":"80520_CR16","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1089\/dna.2005.24.736","volume":"24","author":"YX Pan","year":"2005","unstructured":"Pan, Y. X. Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol. 24, 736\u2013750. https:\/\/doi.org\/10.1089\/dna.2005.24.736 (2005).","journal-title":"DNA Cell Biol."},{"key":"80520_CR17","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani, R. & Bruchas, M. R. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115, 1363\u20131381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6 (2011).","journal-title":"Anesthesiology"},{"key":"80520_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225568","author":"DV Predescu","year":"2019","unstructured":"Predescu, D. V. et al. G protein-coupled receptors (GPCRs)-mediated calcium signaling in ovarian cancer: Focus on GPCRs activated by neurotransmitters and inflammation-associated molecules. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20225568 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"80520_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/bja\/81.1.12","volume":"81","author":"B Jordan","year":"1998","unstructured":"Jordan, B. & Devi, L. A. Molecular mechanisms of opioid receptor signal transduction. Br. J. Anaesth. 81, 12\u201319. https:\/\/doi.org\/10.1093\/bja\/81.1.12 (1998).","journal-title":"Br. J. Anaesth."},{"key":"80520_CR20","doi-asserted-by":"crossref","unstructured":"Law, P. Y. in The Opiate Receptors (ed G. W. Pasternak) 195\u2013238 (Humana Press, 2011).","DOI":"10.1007\/978-1-60761-993-2_9"},{"key":"80520_CR21","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S0021-9258(17)43569-1","volume":"259","author":"JA Hsia","year":"1984","unstructured":"Hsia, J. A., Moss, J., Hewlett, E. L. & Vaughan, M. ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding. J. Biol. Chem. 259, 1086\u20131090 (1984).","journal-title":"J. Biol. Chem."},{"key":"80520_CR22","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3389\/fphar.2018.01388","volume":"9","author":"H Machelska","year":"2018","unstructured":"Machelska, H. & Celik, M. O. Advances in achieving opioid analgesia without side effects. Front. Pharmacol. 9, 1388. https:\/\/doi.org\/10.3389\/fphar.2018.01388 (2018).","journal-title":"Front. Pharmacol."},{"key":"80520_CR23","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1073\/pnas.78.6.3363","volume":"78","author":"KB Seamon","year":"1981","unstructured":"Seamon, K. B., Padgett, W. & Daly, J. W. Forskolin: Unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc. Natl. Acad. Sci. USA 78, 3363\u20133367. https:\/\/doi.org\/10.1073\/pnas.78.6.3363 (1981).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"80520_CR24","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev.pharmtox.40.1.389","volume":"40","author":"PY Law","year":"2000","unstructured":"Law, P. Y., Wong, Y. H. & Loh, H. H. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40, 389\u2013430. https:\/\/doi.org\/10.1146\/annurev.pharmtox.40.1.389 (2000).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"80520_CR25","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1046\/j.1471-4159.1995.65062682.x","volume":"65","author":"JS Chan","year":"1995","unstructured":"Chan, J. S., Chiu, T. T. & Wong, Y. H. Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: Coupling to multiple G proteins. J. Neurochem. 65, 2682\u20132689. https:\/\/doi.org\/10.1046\/j.1471-4159.1995.65062682.x (1995).","journal-title":"J. Neurochem."},{"key":"80520_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1124\/mol.56.5.902","volume":"56","author":"SH Yoon","year":"1999","unstructured":"Yoon, S. H., Lo, T. M., Loh, H. H. & Thayer, S. A. Delta-opioid-induced liberation of Gbetagamma mobilizes Ca2+ stores in NG108-15 cells. Mol. Pharmacol. 56, 902\u2013908. https:\/\/doi.org\/10.1124\/mol.56.5.902 (1999).","journal-title":"Mol. Pharmacol."},{"key":"80520_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.bbi.2016.04.018","volume":"57","author":"MO Celik","year":"2016","unstructured":"Celik, M. O. et al. Leukocyte opioid receptors mediate analgesia via Ca(2+)-regulated release of opioid peptides. Brain Behav. Immun. 57, 227\u2013242. https:\/\/doi.org\/10.1016\/j.bbi.2016.04.018 (2016).","journal-title":"Brain Behav. Immun."},{"key":"80520_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1124\/mol.63.1.89","volume":"63","author":"AC Charles","year":"2003","unstructured":"Charles, A. C. et al. Coexpression of delta-opioid receptors with micro receptors in GH3 cells changes the functional response to micro agonists from inhibitory to excitatory. Mol. Pharmacol. 63, 89\u201395. https:\/\/doi.org\/10.1124\/mol.63.1.89 (2003).","journal-title":"Mol. Pharmacol."},{"key":"80520_CR29","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1046\/j.1471-4159.1994.62031009.x","volume":"62","author":"D Smart","year":"1994","unstructured":"Smart, D., Smith, G. & Lambert, D. G. mu-Opioid receptor stimulation of inositol (1,4,5)trisphosphate formation via a pertussis toxin-sensitive G protein. J. Neurochem. 62, 1009\u20131014. https:\/\/doi.org\/10.1046\/j.1471-4159.1994.62031009.x (1994).","journal-title":"J. Neurochem."},{"key":"80520_CR30","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/sj.cdd.4400539","volume":"6","author":"SN Orlov","year":"1999","unstructured":"Orlov, S. N. et al. Activation of cAMP signaling transiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3. Cell Death Differ. 6, 661\u2013672. https:\/\/doi.org\/10.1038\/sj.cdd.4400539 (1999).","journal-title":"Cell Death Differ."},{"key":"80520_CR31","doi-asserted-by":"publisher","first-page":"5910","DOI":"10.1038\/onc.2017.211","volume":"36","author":"SM Kang","year":"2017","unstructured":"Kang, S. M. et al. Genome-wide loss-of-function genetic screening identifies opioid receptor mu1 as a key regulator of l-asparaginase resistance in pediatric acute lymphoblastic leukemia. Oncogene 36, 5910\u20135913. https:\/\/doi.org\/10.1038\/onc.2017.211 (2017).","journal-title":"Oncogene"},{"key":"80520_CR32","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","volume":"260","author":"G Grynkiewicz","year":"1985","unstructured":"Grynkiewicz, G., Poenie, M. & Tsien, R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440\u20133450 (1985).","journal-title":"J. Biol. Chem."},{"key":"80520_CR33","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00432-010-0961-1","volume":"137","author":"R Kaufmann","year":"2011","unstructured":"Kaufmann, R., Mussbach, F., Henklein, P. & Settmacher, U. Proteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells. J. Cancer. Res. Clin. Oncol. 137, 965\u2013973. https:\/\/doi.org\/10.1007\/s00432-010-0961-1 (2011).","journal-title":"J. Cancer. Res. Clin. Oncol."},{"key":"80520_CR34","doi-asserted-by":"publisher","first-page":"7736","DOI":"10.1074\/jbc.M114.618827","volume":"290","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. Roles of the NH2-terminal domains of cardiac ryanodine receptor in Ca2+ release activation and termination. J. Biol. Chem. 290, 7736\u20137746. https:\/\/doi.org\/10.1074\/jbc.M114.618827 (2015).","journal-title":"J. Biol. Chem."},{"key":"80520_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.mex.2016.05.004","volume":"3","author":"DS Kiss","year":"2016","unstructured":"Kiss, D. S. et al. Preparation of purified perikaryal and synaptosomal mitochondrial fractions from relatively small hypothalamic brain samples. MethodsX 3, 417\u2013429. https:\/\/doi.org\/10.1016\/j.mex.2016.05.004 (2016).","journal-title":"MethodsX"},{"key":"80520_CR36","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/s0896-6273(01)80032-5","volume":"23","author":"JL Whistler","year":"1999","unstructured":"Whistler, J. L., Chuang, H. H., Chu, P., Jan, L. Y. & von Zastrow, M. Functional dissociation of mu opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction. Neuron 23, 737\u2013746. https:\/\/doi.org\/10.1016\/s0896-6273(01)80032-5 (1999).","journal-title":"Neuron"},{"key":"80520_CR37","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/s0014-2999(98)00871-1","volume":"365","author":"CR Jan","year":"1999","unstructured":"Jan, C. R., Ho, C. M., Wu, S. N. & Tseng, C. J. Mechanism of rise and decay of 2,5-di-tert-butylhydroquinone-induced Ca2+ signals in Madin Darby canine kidney cells. Eur. J. Pharmacol. 365, 111\u2013117. https:\/\/doi.org\/10.1016\/s0014-2999(98)00871-1 (1999).","journal-title":"Eur. J. Pharmacol."},{"key":"80520_CR38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1152\/physrev.1999.79.4.1089","volume":"79","author":"A Takahashi","year":"1999","unstructured":"Takahashi, A., Camacho, P., Lechleiter, J. D. & Herman, B. Measurement of intracellular calcium. Physiol. Rev. 79, 1089\u20131125. https:\/\/doi.org\/10.1152\/physrev.1999.79.4.1089 (1999).","journal-title":"Physiol. Rev."},{"key":"80520_CR39","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1172\/JCI117739","volume":"95","author":"LO Go","year":"1995","unstructured":"Go, L. O. et al. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J. Clin. Invest. 95, 888\u2013894. https:\/\/doi.org\/10.1172\/JCI117739 (1995).","journal-title":"J. Clin. Invest."},{"key":"80520_CR40","doi-asserted-by":"publisher","first-page":"798","DOI":"10.15252\/embj.201489056","volume":"34","author":"P Solanes","year":"2015","unstructured":"Solanes, P. et al. Space exploration by dendritic cells requires maintenance of myosin II activity by IP3 receptor 1. EMBO J. 34, 798\u2013810. https:\/\/doi.org\/10.15252\/embj.201489056 (2015).","journal-title":"EMBO J."},{"key":"80520_CR41","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1113\/jphysiol.2011.222083","volume":"590","author":"EB Westcott","year":"2012","unstructured":"Westcott, E. B., Goodwin, E. L., Segal, S. S. & Jackson, W. F. Function and expression of ryanodine receptors and inositol 1,4,5-trisphosphate receptors in smooth muscle cells of murine feed arteries and arterioles. J. Physiol. 590, 1849\u20131869. https:\/\/doi.org\/10.1113\/jphysiol.2011.222083 (2012).","journal-title":"J. Physiol."},{"key":"80520_CR42","doi-asserted-by":"publisher","first-page":"16175","DOI":"10.1074\/jbc.M414552200","volume":"280","author":"J Takano","year":"2005","unstructured":"Takano, J. et al. Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J. Biol. Chem. 280, 16175\u201316184. https:\/\/doi.org\/10.1074\/jbc.M414552200 (2005).","journal-title":"J. Biol. Chem."},{"key":"80520_CR43","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1101\/gad.10.22.2859","volume":"10","author":"K Wang","year":"1996","unstructured":"Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L. & Korsmeyer, S. J. BID: A novel BH3 domain-only death agonist. Genes Dev. 10, 2859\u20132869. https:\/\/doi.org\/10.1101\/gad.10.22.2859 (1996).","journal-title":"Genes Dev."},{"key":"80520_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","volume":"28","author":"MR Hutchinson","year":"2008","unstructured":"Hutchinson, M. R. et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4). Eur. J. Neurosci. 28, 20\u201329. https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06321.x (2008).","journal-title":"Eur. J. Neurosci."},{"key":"80520_CR45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0006-8993(96)00191-6","volume":"722","author":"Y Sarne","year":"1996","unstructured":"Sarne, Y. & Gafni, M. Determinants of the stimulatory opioid effect on intracellular calcium in SK-N-SH and NG108-15 neuroblastoma. Brain Res. 722, 203\u2013206. https:\/\/doi.org\/10.1016\/0006-8993(96)00191-6 (1996).","journal-title":"Brain Res."},{"key":"80520_CR46","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1523\/JNEUROSCI.14-04-01920.1994","volume":"14","author":"W Jin","year":"1994","unstructured":"Jin, W., Lee, N. M., Loh, H. H. & Thayer, S. A. Opioids mobilize calcium from inositol 1,4,5-trisphosphate-sensitive stores in NG108-15 cells. J. Neurosci. 14, 1920\u20131929 (1994).","journal-title":"J. Neurosci."},{"key":"80520_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1258\/000456305774538238","volume":"42","author":"SM Harwood","year":"2005","unstructured":"Harwood, S. M., Yaqoob, M. M. & Allen, D. A. Caspase and calpain function in cell death: Bridging the gap between apoptosis and necrosis. Ann. Clin. Biochem. 42, 415\u2013431. https:\/\/doi.org\/10.1258\/000456305774538238 (2005).","journal-title":"Ann. Clin. Biochem."},{"key":"80520_CR48","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1128\/mcb.22.9.3003-3013.2002","volume":"22","author":"A Mandic","year":"2002","unstructured":"Mandic, A. et al. Calpain-mediated Bid cleavage and calpain-independent Bak modulation: Two separate pathways in cisplatin-induced apoptosis. Mol. Cell Biol. 22, 3003\u20133013. https:\/\/doi.org\/10.1128\/mcb.22.9.3003-3013.2002 (2002).","journal-title":"Mol. Cell Biol."},{"key":"80520_CR49","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature07396","volume":"455","author":"E Gavathiotis","year":"2008","unstructured":"Gavathiotis, E. et al. BAX activation is initiated at a novel interaction site. Nature 455, 1076\u20131081. https:\/\/doi.org\/10.1038\/nature07396 (2008).","journal-title":"Nature"},{"key":"80520_CR50","doi-asserted-by":"publisher","first-page":"106713","DOI":"10.1155\/2014\/106713","volume":"2014","author":"PT Diamantopoulos","year":"2014","unstructured":"Diamantopoulos, P. T. et al. PARP1-driven apoptosis in chronic lymphocytic leukemia. Biomed. Res. Int. 2014, 106713. https:\/\/doi.org\/10.1155\/2014\/106713 (2014).","journal-title":"Biomed. Res. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80520-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80520-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80520-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:08:49Z","timestamp":1670033329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-80520-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,13]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["80520"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-80520-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,13]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1009"}}